PMGC Holdings (ELAB) EBT (2022 - 2026)
PMGC Holdings' (ELAB) quarterly EBT came in at -$4.3 million in Q2 2026, down 15.54% quarter-over-quarter from -$3.7 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) EBT (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed EBT across 5 years of filings, most recently posting -$4.3 million for Q2 2026.
- In Q2 2026, EBT changed N/A year-over-year to -$4.3 million; the TTM figure through Jun 2026 stood at -$13.0 million (changed N/A YoY), while the FY2025 annual figure was $8.4 million, changed N/A from the prior year.
- EBT came in at -$4.3 million for Q2 2026 at PMGC Holdings, down from -$3.7 million in the prior quarter.
- In the past five years, EBT ranged from a high of $1.1 billion in Q4 2022 to a low of -$469.3 million in Q3 2022.
- Average EBT over 5 years is $48.0 million, with a median of -$1.6 million recorded in 2024.
- The largest YoY upside for EBT was 99.83% in 2023 against a maximum downside of 100.1% in 2023.
- Over 5 years, EBT stood at $1.1 billion in 2022, then slumped by 100.1% to -$1.1 million in 2023, then tumbled by 44.17% to -$1.6 million in 2024, then plunged by 63.36% to -$2.6 million in 2025, then plunged by 68.89% to -$4.3 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$4.3 million in Q2 2026, -$3.7 million in Q1 2026, and -$2.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.11 Bn | 193.12 Bn | 7.24 Bn | 2.77 Bn |
| 2 | Gilead Sciences | 178.91 Bn | 175.73 Bn | 6.22 Bn | -10.25 Bn |
| 3 | Vertex Pharmaceuticals | 131.35 Bn | 123.50 Bn | 2.84 Bn | 1.39 Bn |
| 4 | Regeneron Pharmaceuticals | 81.84 Bn | 73.85 Bn | 3.93 Bn | 1.53 Bn |
| 5 | Argenx Se | 61.06 Bn | 55.87 Bn | 1.37 Bn | 542.00 Mn |
| 6 | Moderna | 53.08 Bn | 47.94 Bn | 52.00 Mn | -767.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.32 Bn | 30.01 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Biogen | 31.70 Bn | 30.41 Bn | 1.96 Bn | 132.40 Mn |
| 9 | Roivant Sciences | 29.48 Bn | 29.48 Bn | 1.16 Mn | -294.56 Mn |
| 10 | PMGC Holdings | 2.23 Mn | -16.56 Mn | 385,691.00 | -4.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.33 Mn |
| Mar 31, 2026 | -3.74 Mn |
| Dec 31, 2025 | -2.56 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Sep 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | -1.44 Mn |
| Mar 31, 2024 | -1.68 Mn |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | -791,239.00 |
| Jun 30, 2023 | -1.06 Mn |
| Mar 31, 2023 | -841,282.00 |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | -469.32 Mn |